1. Home
  2. TENX vs NWGL Comparison

TENX vs NWGL Comparison

Compare TENX & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • NWGL
  • Stock Information
  • Founded
  • TENX 1967
  • NWGL 2008
  • Country
  • TENX United States
  • NWGL Macau
  • Employees
  • TENX N/A
  • NWGL N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • NWGL
  • Sector
  • TENX Health Care
  • NWGL
  • Exchange
  • TENX Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • TENX 21.6M
  • NWGL 21.2M
  • IPO Year
  • TENX N/A
  • NWGL 2023
  • Fundamental
  • Price
  • TENX $5.68
  • NWGL $1.30
  • Analyst Decision
  • TENX Strong Buy
  • NWGL
  • Analyst Count
  • TENX 3
  • NWGL 0
  • Target Price
  • TENX $16.00
  • NWGL N/A
  • AVG Volume (30 Days)
  • TENX 12.6K
  • NWGL 10.5K
  • Earning Date
  • TENX 05-14-2025
  • NWGL 05-27-2025
  • Dividend Yield
  • TENX N/A
  • NWGL N/A
  • EPS Growth
  • TENX N/A
  • NWGL N/A
  • EPS
  • TENX N/A
  • NWGL N/A
  • Revenue
  • TENX N/A
  • NWGL $21,539,347.00
  • Revenue This Year
  • TENX N/A
  • NWGL N/A
  • Revenue Next Year
  • TENX N/A
  • NWGL N/A
  • P/E Ratio
  • TENX N/A
  • NWGL N/A
  • Revenue Growth
  • TENX N/A
  • NWGL N/A
  • 52 Week Low
  • TENX $2.77
  • NWGL $1.04
  • 52 Week High
  • TENX $7.89
  • NWGL $3.37
  • Technical
  • Relative Strength Index (RSI)
  • TENX 49.30
  • NWGL 44.72
  • Support Level
  • TENX $5.49
  • NWGL $1.23
  • Resistance Level
  • TENX $5.87
  • NWGL $1.56
  • Average True Range (ATR)
  • TENX 0.27
  • NWGL 0.14
  • MACD
  • TENX 0.03
  • NWGL -0.01
  • Stochastic Oscillator
  • TENX 52.04
  • NWGL 16.67

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: